Back to search results
Recruiting

Parkinson's Disease Dementia, Lewy Body Dementia

A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated with Idiopathic Parkinson’s Disease (PD) or Dementia with Lewy Bodies (DLB) (PRESENCE)

HBEH | {{ defaultRegistry.registryAnchorText }} NCT03305809 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

A randomized placebo-controlled trial to evaluate the safety and efficacy of three doses of study drug LY3154207 treated for 12 weeks in participants with mild-to-moderate dementia associated with LBD (PDD or DLB).

Time Commitment

Your participation could last approximately 18 weeks and include 12 visits to the study center.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

40 years
85 years

• Participant must have dementia

• Participant must have Parkinson's Disease or dementia with Lewy bodies

• Participants on anti-parkinsonian agents, must be on stable doses for at least 3 weeks prior to entering study

• Participants on antidepressant medications, must be on stable doses for at least 3 weeks prior to entering study

• Participants on blood pressure lowering medications, must be on stable doses for at least 3 weeks prior to entering study

• Male participant must use appropriate contraception. Female participant must not be of childbearing potential

• Participant must have a reliable caregiver who is in frequent contact with participant and will accompany participant to select visits

• Participant must not have a history of stroke in the last 6 months

• Participant must not have a current or any previous diagnosis of bipolar disorder, schizophrenia, or other primary psychotic disorder

• Participant must not have a history of substance abuse within the past 1 year, and/or substance dependence within the past 1 year, not including caffeine and nicotine

Where to Participate

Where to Participate

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.